Affiliation:
1. 1Sarah Cannon Research Institute, Nashville, Tennessee.
2. 2European Alliance for Personalized Medicine, Brussels, Belgium.
3. 3The US Oncology Network, The Woodlands, Texas.
Abstract
Summary:
Revolutionary advancements in oncology have transformed lives, but the clinical trials ecosystem encounters challenges, including restricted access to innovative therapies and a lack of diversity in participant representation. A vision emerges for democratized, globally accessible oncology trials, necessitating collaboration among researchers, clinicians, patients, and policymakers to shift from converting complex, exclusive trials into a dynamic, inclusive force against cancer.
Publisher
American Association for Cancer Research (AACR)
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献